Smith & Nephew plc (NYSE:SNN) Shares Purchased by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. increased its holdings in shares of Smith & Nephew plc (NYSE:SNN) by 1.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 114,226 shares of the medical equipment provider’s stock after acquiring an additional 1,367 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Smith & Nephew were worth $2,808,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in SNN. Rhumbline Advisers lifted its position in Smith & Nephew by 8.6% in the second quarter. Rhumbline Advisers now owns 10,365 shares of the medical equipment provider’s stock valued at $257,000 after buying an additional 819 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of Smith & Nephew by 9.3% in the 2nd quarter. American Century Companies Inc. now owns 119,347 shares of the medical equipment provider’s stock worth $2,957,000 after acquiring an additional 10,156 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Smith & Nephew by 58.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock worth $12,995,000 after purchasing an additional 193,046 shares during the period. Vanguard Personalized Indexing Management LLC boosted its position in shares of Smith & Nephew by 62.4% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 23,752 shares of the medical equipment provider’s stock worth $589,000 after purchasing an additional 9,124 shares during the period. Finally, XTX Topco Ltd acquired a new stake in Smith & Nephew in the 2nd quarter valued at approximately $256,000. 25.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on SNN. Deutsche Bank Aktiengesellschaft cut Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Berenberg Bank downgraded Smith & Nephew from a “buy” rating to a “hold” rating in a report on Wednesday, November 6th. Finally, StockNews.com downgraded Smith & Nephew from a “strong-buy” rating to a “buy” rating in a report on Tuesday, November 12th.

Smith & Nephew Trading Down 2.1 %

Shares of Smith & Nephew stock opened at $25.18 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. The company has a fifty day simple moving average of $25.01 and a 200-day simple moving average of $27.78. Smith & Nephew plc has a 12-month low of $23.65 and a 12-month high of $31.72.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.